Moreover, following butyrate supplementation, many of the CRC-relevant genes monitored throughout the study, such as MYC and FOSL1, showed a threefold to sevenfold reduction in Kbu binding affinity in the normal cell line compared to the CRC cell line (Extended Data Fig. 5e–h). The gene discussed is MYC; the disease is colorectal carcinoma.